Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As2O3) and all-trans retinoic acid (ATRA)-Reference-Cited by-同舟云学术

Long-term control of refractory follicular lymphoma after treatment of secondary acute promyelocytic leukemia with arsenic trioxide (As2O3) and all-trans retinoic acid (ATRA)

Published:2018 Issue:2 Volume:53 Page:169
ISSN:2287-979X
Container-title:Blood Research
language:en
Short-container-title:Blood Res

Author:

Jain Preetesh¹,Konoplev Sergej²,Benjamini Ohad¹,Romagura Jorge³,Burger Jan A.¹

Affiliation:

1. Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

2. Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

3. Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

Publisher

The Korean Society of Hematology

Subject

Hematology

Link

https://synapse.koreamed.org/pdf/10.5045/br.2018.53.2.169

Reference12 articles.

1. Follicular Lymphoma: Prognostic Factors, Conventional Therapies, and Hematopoietic Cell Transplantation

2. How to manage acute promyelocytic leukemia

3. Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

4. A phase II study of arsenic trioxide in patients with relapsed or refractory malignant lymphoma

5. Combination Therapy with Arsenic Trioxide for Hematological Malignancies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c-acute myeloid leukemia;Haematologica;2021-05-27

2. Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review;International Review of Neurobiology;2020